Jenkins A L, Bootman M D, Taylor C W, Mackie E J, Stone S R
Department of Haematology, University of Cambridge, United Kingdom.
J Biol Chem. 1993 Oct 5;268(28):21432-7.
The receptor responsible for the increase in intracellular calcium concentration ([Ca2+]i) after the addition of thrombin to the human osteoblast-like cell line Saos-2 has been characterized. Thrombin caused a dose-dependent increase in [Ca2+]i; a half-maximal stimulation was observed with 3.2 +/- 1.1 nM thrombin. The human platelet thrombin receptor is activated by thrombin cleavage to create a new NH2 terminus that acts as a tethered ligand, and peptides based on the tethered ligand can activate the receptor independently of thrombin. Northern analysis indicated the presence of mRNA encoding the platelet receptor in Saos-2 cells, and surface expression of the receptor was demonstrated by immunocytochemistry. A tethered ligand peptide (SFLLRNPNDKYEPF, single-letter amino acid code) was found to increase [Ca2+]i. The maximal response to the peptide was similar to that observed with thrombin, and a half-maximal response was observed with 22 +/- 6 microM peptide. The time course of the increase in [Ca2+]i with the peptide was different than that observed with thrombin; a pronounced shoulder was observed after an initial sharp rise. The phenylalanine in the second position of the agonist peptide and the arginine in the fifth position were shown to be essential for its activity. The requirement for proteolysis of the receptor for the thrombin-dependent increase in [Ca2+]i was demonstrated by two methods. Antibodies that reacted with the cleavage site of the receptor abolished the effect of thrombin on [Ca2+]i. In addition, a mutant of thrombin without catalytic activity as well as chemically inactivated thrombin failed to cause an increase in [Ca2+]i. Similar results were obtained with the rat osteoblast-like cell line UMR-106; a tethered ligand peptide based on the rat sequence induced an increase in [Ca2+]i, and antibodies to the cleavage site of the rat receptor inhibited the effect of thrombin.
已对向人成骨细胞样细胞系Saos-2中添加凝血酶后细胞内钙浓度([Ca2+]i)升高所涉及的受体进行了表征。凝血酶使[Ca2+]i呈剂量依赖性升高;在3.2±1.1 nM凝血酶时观察到半数最大刺激。人血小板凝血酶受体通过凝血酶切割而活化,产生一个作为拴系配体的新NH2末端,基于拴系配体的肽可独立于凝血酶激活该受体。Northern分析表明Saos-2细胞中存在编码血小板受体的mRNA,免疫细胞化学证明了该受体的表面表达。发现一种拴系配体肽(SFLLRNPNDKYEPF,单字母氨基酸编码)可升高[Ca2+]i。该肽的最大反应与凝血酶所观察到的相似,在22±6 μM肽时观察到半数最大反应。肽引起的[Ca2+]i升高的时间进程与凝血酶所观察到的不同;在最初急剧上升后观察到明显的平台期。激动剂肽第二位的苯丙氨酸和第五位的精氨酸对其活性至关重要。通过两种方法证明了凝血酶依赖性[Ca2+]i升高对受体蛋白水解的需求。与受体切割位点反应的抗体消除了凝血酶对[Ca2+]i的作用。此外,无催化活性的凝血酶突变体以及化学灭活的凝血酶均未能引起[Ca2+]i升高。用大鼠成骨细胞样细胞系UMR-106获得了类似结果;基于大鼠序列的拴系配体肽诱导[Ca2+]i升高,针对大鼠受体切割位点的抗体抑制了凝血酶作用。